Co-Diagnostics Moves Closer to Commercial Tuberculosis Test Launch in India
Co-Diagnostics filed for Indian clearance for its rapid TB test following successful trials, targeting commercial sales before the year-end.
Share
Why It Matters
Co-Diagnostics got permission to sell a fast TB test in India. Watch if they hit their sales target before year-end.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.
